BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22669676)

  • 1. A review of toxicogenomic approaches in developmental toxicology.
    Robinson JF; Pennings JL; Piersma AH
    Methods Mol Biol; 2012; 889():347-71. PubMed ID: 22669676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicogenomic approaches in developmental toxicology testing.
    Robinson JF; Piersma AH
    Methods Mol Biol; 2013; 947():451-73. PubMed ID: 23138921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of gene expression responses in rat whole embryo culture and in vivo: time-dependent retinoic acid-induced teratogenic response.
    Robinson JF; Verhoef A; Pennings JL; Pronk TE; Piersma AH
    Toxicol Sci; 2012 Mar; 126(1):242-54. PubMed ID: 22262565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of MeHg-induced toxicogenomic responses across in vivo and in vitro models used in developmental toxicology.
    Robinson JF; Theunissen PT; van Dartel DA; Pennings JL; Faustman EM; Piersma AH
    Reprod Toxicol; 2011 Sep; 32(2):180-8. PubMed ID: 21664453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter- and intra-laboratory study to determine the reproducibility of toxicogenomics datasets.
    Scott DJ; Devonshire AS; Adeleye YA; Schutte ME; Rodrigues MR; Wilkes TM; Sacco MG; Gribaldo L; Fabbri M; Coecke S; Whelan M; Skinner N; Bennett A; White A; Foy CA
    Toxicology; 2011 Nov; 290(1):50-8. PubMed ID: 21871943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
    Youns M; Hoheisel JD; Efferth T
    Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping molecular responses to xenoestrogens through Gene Ontology and pathway analysis of toxicogenomic data.
    Currie RA; Orphanides G; Moggs JG
    Reprod Toxicol; 2005; 20(3):433-40. PubMed ID: 15964738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In pursuit of effective toxicogenomics.
    Gant TW; Zhang SD
    Mutat Res; 2005 Aug; 575(1-2):4-16. PubMed ID: 15885710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of toxicogenomic data in risk assessment: a regulatory perspective.
    Chan VS; Theilade MD
    Clin Toxicol (Phila); 2005; 43(2):121-6. PubMed ID: 15822767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicogenomics and systems toxicology: aims and prospects.
    Waters MD; Fostel JM
    Nat Rev Genet; 2004 Dec; 5(12):936-48. PubMed ID: 15573125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicogenomics in predictive toxicology in drug development.
    Suter L; Babiss LE; Wheeldon EB
    Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryotoxicant-specific transcriptomic responses in rat postimplantation whole-embryo culture.
    Robinson JF; van Beelen VA; Verhoef A; Renkens MF; Luijten M; van Herwijnen MH; Westerman A; Pennings JL; Piersma AH
    Toxicol Sci; 2010 Dec; 118(2):675-85. PubMed ID: 20864626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
    Merrick BA; Bruno ME
    Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
    Lühe A; Suter L; Ruepp S; Singer T; Weiser T; Albertini S
    Mutat Res; 2005 Aug; 575(1-2):102-15. PubMed ID: 15924886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomics-based identification of developmental toxicants through their interference with cardiomyocyte differentiation of embryonic stem cells.
    van Dartel DA; Pennings JL; van Schooten FJ; Piersma AH
    Toxicol Appl Pharmacol; 2010 Mar; 243(3):420-8. PubMed ID: 20036270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicogenomics in genetic toxicology and hazard determination--concluding remarks.
    Sarrif A; van Delft JH; Gant TW; Kleinjans JC; van Vliet E
    Mutat Res; 2005 Aug; 575(1-2):116-7. PubMed ID: 15924887
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of microarray-based analysis of gene expression in the field of toxicogenomics.
    Mei N; Fuscoe JC; Lobenhofer EK; Guo L
    Methods Mol Biol; 2010; 597():227-41. PubMed ID: 20013237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A decade of toxicogenomic research and its contribution to toxicological science.
    Chen M; Zhang M; Borlak J; Tong W
    Toxicol Sci; 2012 Dec; 130(2):217-28. PubMed ID: 22790972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base.
    Waters M; Boorman G; Bushel P; Cunningham M; Irwin R; Merrick A; Olden K; Paules R; Selkirk J; Stasiewicz S; Weis B; Van Houten B; Walker N; Tennant R
    EHP Toxicogenomics; 2003 Jan; 111(1T):15-28. PubMed ID: 12735106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a data dependent analysis (DDA) yeast cDNA microarray experiment for use in toxicogenomics.
    Mizukami S; Suzuki Y; Kitagawa E; Momose Y; Kim HJ; Iwahashi H
    Environ Sci; 2004; 11(6):325-35. PubMed ID: 15750578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.